Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine

COVID-19 has caused widespread morbidity and mortality, with its effects extending to multiple organ systems. Despite known risk factors for severe disease, including advanced age and underlying comorbidities, patient outcomes can vary significantly. This variability complicates efforts to predict d...

Full description

Saved in:
Bibliographic Details
Main Authors: Heba M. Saad Eldien, Abdulrahman H. Almaeen, Ahmed Abo El Fath, Ahmed E. Taha, Rehab Ahmed, Hassabelrasoul Elfadil, Helal F. Hetta
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/2/229
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588712730427392
author Heba M. Saad Eldien
Abdulrahman H. Almaeen
Ahmed Abo El Fath
Ahmed E. Taha
Rehab Ahmed
Hassabelrasoul Elfadil
Helal F. Hetta
author_facet Heba M. Saad Eldien
Abdulrahman H. Almaeen
Ahmed Abo El Fath
Ahmed E. Taha
Rehab Ahmed
Hassabelrasoul Elfadil
Helal F. Hetta
author_sort Heba M. Saad Eldien
collection DOAJ
description COVID-19 has caused widespread morbidity and mortality, with its effects extending to multiple organ systems. Despite known risk factors for severe disease, including advanced age and underlying comorbidities, patient outcomes can vary significantly. This variability complicates efforts to predict disease progression and tailor treatment strategies. While diagnostic and therapeutic approaches are still under debate, RNA sequencing (RNAseq) has emerged as a promising tool to provide deeper insights into the pathophysiology of COVID-19 and guide personalized treatment. A comprehensive literature review was conducted using PubMed, Scopus, Web of Science, and Google Scholar. We employed Medical Subject Headings (MeSH) terms and relevant keywords to identify studies that explored the role of RNAseq in COVID-19 diagnostics, prognostics, and therapeutics. RNAseq has proven instrumental in identifying molecular biomarkers associated with disease severity in patients with COVID-19. It allows for the differentiation between asymptomatic and symptomatic individuals and sheds light on the immune response mechanisms that contribute to disease progression. In critically ill patients, RNAseq has been crucial for identifying key genes that may predict patient outcomes, guiding therapeutic decisions, and assessing the long-term effects of the virus. Additionally, RNAseq has helped in understanding the persistence of viral RNA after recovery, offering new insights into the management of post-acute sequelae, including long COVID. RNA sequencing significantly improves COVID-19 management, particularly for critically ill patients, by enhancing diagnostic accuracy, personalizing treatment, and predicting therapeutic responses. It refines patient stratification, improving outcomes, and holds promise for targeted interventions in both acute and long COVID.
format Article
id doaj-art-903a43d1281d41b4ae5d9af40e15ce17
institution Kabale University
issn 2075-4418
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-903a43d1281d41b4ae5d9af40e15ce172025-01-24T13:29:11ZengMDPI AGDiagnostics2075-44182025-01-0115222910.3390/diagnostics15020229Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized MedicineHeba M. Saad Eldien0Abdulrahman H. Almaeen1Ahmed Abo El Fath2Ahmed E. Taha3Rehab Ahmed4Hassabelrasoul Elfadil5Helal F. Hetta6Department of Anatomy, College of Medicine, Jouf University, Sakaka 72388, Saudi ArabiaDepartment of Pathology, College of Medicine, Jouf University, Sakaka 72388, Saudi ArabiaTropical Medicine and Gastroenterology Department, Assiut University Hospital, Assiut 71515, EgyptMicrobiology and Immunology Unit, Department of Pathology, College of Medicine, Jouf University, Sakaka 72388, Saudi ArabiaDivision of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi ArabiaDivision of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi ArabiaDivision of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi ArabiaCOVID-19 has caused widespread morbidity and mortality, with its effects extending to multiple organ systems. Despite known risk factors for severe disease, including advanced age and underlying comorbidities, patient outcomes can vary significantly. This variability complicates efforts to predict disease progression and tailor treatment strategies. While diagnostic and therapeutic approaches are still under debate, RNA sequencing (RNAseq) has emerged as a promising tool to provide deeper insights into the pathophysiology of COVID-19 and guide personalized treatment. A comprehensive literature review was conducted using PubMed, Scopus, Web of Science, and Google Scholar. We employed Medical Subject Headings (MeSH) terms and relevant keywords to identify studies that explored the role of RNAseq in COVID-19 diagnostics, prognostics, and therapeutics. RNAseq has proven instrumental in identifying molecular biomarkers associated with disease severity in patients with COVID-19. It allows for the differentiation between asymptomatic and symptomatic individuals and sheds light on the immune response mechanisms that contribute to disease progression. In critically ill patients, RNAseq has been crucial for identifying key genes that may predict patient outcomes, guiding therapeutic decisions, and assessing the long-term effects of the virus. Additionally, RNAseq has helped in understanding the persistence of viral RNA after recovery, offering new insights into the management of post-acute sequelae, including long COVID. RNA sequencing significantly improves COVID-19 management, particularly for critically ill patients, by enhancing diagnostic accuracy, personalizing treatment, and predicting therapeutic responses. It refines patient stratification, improving outcomes, and holds promise for targeted interventions in both acute and long COVID.https://www.mdpi.com/2075-4418/15/2/229COVID-19RNAseqtranscriptomehost responsesgeneprecision medicine
spellingShingle Heba M. Saad Eldien
Abdulrahman H. Almaeen
Ahmed Abo El Fath
Ahmed E. Taha
Rehab Ahmed
Hassabelrasoul Elfadil
Helal F. Hetta
Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine
Diagnostics
COVID-19
RNAseq
transcriptome
host responses
gene
precision medicine
title Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine
title_full Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine
title_fullStr Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine
title_full_unstemmed Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine
title_short Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine
title_sort unlocking the potential of rna sequencing in covid 19 toward accurate diagnosis and personalized medicine
topic COVID-19
RNAseq
transcriptome
host responses
gene
precision medicine
url https://www.mdpi.com/2075-4418/15/2/229
work_keys_str_mv AT hebamsaadeldien unlockingthepotentialofrnasequencingincovid19towardaccuratediagnosisandpersonalizedmedicine
AT abdulrahmanhalmaeen unlockingthepotentialofrnasequencingincovid19towardaccuratediagnosisandpersonalizedmedicine
AT ahmedaboelfath unlockingthepotentialofrnasequencingincovid19towardaccuratediagnosisandpersonalizedmedicine
AT ahmedetaha unlockingthepotentialofrnasequencingincovid19towardaccuratediagnosisandpersonalizedmedicine
AT rehabahmed unlockingthepotentialofrnasequencingincovid19towardaccuratediagnosisandpersonalizedmedicine
AT hassabelrasoulelfadil unlockingthepotentialofrnasequencingincovid19towardaccuratediagnosisandpersonalizedmedicine
AT helalfhetta unlockingthepotentialofrnasequencingincovid19towardaccuratediagnosisandpersonalizedmedicine